Item 5.07. Submission of Matters to a Vote of Security Holders.
(a) On November 20, 2021, NanoViricides, Inc. (the "Registrant") held its
2021 Annual Meeting of Stockholders (the "Meeting"). Of the 11,515,170 shares of
the Company's common stock and 481,694 shares of Series A Convertible Preferred
Stock ("Series A Preferred Shares") entitled to vote at the Meeting, an
aggregate of 60.7% of the Registrant's securities entitled to vote were present
in person or by proxy, representing a majority of the Company's outstanding
voting capital stock.
(b) At the Meeting, the Company's stockholders re-elected Anil Diwan as a
Class 1 director for a two-year term expiring at the 2023 annual meeting of
stockholders and until his successor is duly elected and qualified or until his
earlier resignation or removal. The Company's stockholders voted in favor to
hold an advisory vote on executive compensation of the Registrant's Named
Executive Officers every three years. The Company's stockholders voted in favor
of an award of 10,204 Series A Preferred Shares to Anil Diwan in connection with
the extension of his employment as the Company's President. The Company's
stockholders also ratified the appointment of EisnerAmper, LLP as the Company's
independent registered public accounting firm for the fiscal year ending June
30, 2022. Each proposal is described in more detail in the Company's Proxy
Statement filed with the Securities and Exchange Commission on October 12, 2021.
The voting results of the shares of Common Stock and Series A Preferred Shares
for each proposal are set forth below:
Proposal 1 - Election of Director:
Re-Election of Anil Diwan as a Class I Director:
Votes For Votes Against/Withheld
5,242,989 137,944
Proposal 2 - Approval of a Three-Year Interval for Advisory Vote on Executive
Compensation:
Votes For One Votes For Two Votes For Three
Year Years Years
357,604 90,293 4,925,150
Proposal 3 - Approval Convertible Preferred Stock Grant to Anil Diwan:
Votes For Votes Against Votes Abstained
5,028,342 343,312 34,352
Proposal 4 - To ratify the appointment of EisnerAmper, LLP as the Company's
independent registered public accounting firm for the fiscal year ending June
30, 2022:
Votes For Votes Against Votes Abstained
8,638,812 372,551 114,153
© Edgar Online, source Glimpses